Cover Image
市場調查報告書

抗體生產市場:分析與各市場區隔的預測

Antibody Production Market By Type (Polyclonal Antibody, Monoclonal Antibody), By Process (Upstream Processing, Downstream Processing, Filtration), By End-Use, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 490506
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
抗體生產市場:分析與各市場區隔的預測 Antibody Production Market By Type (Polyclonal Antibody, Monoclonal Antibody), By Process (Upstream Processing, Downstream Processing, Filtration), By End-Use, And Segment Forecasts, 2014 - 2025
出版日期: 2017年03月01日 內容資訊: 英文 90 Pages
簡介

本報告提供全球抗體生產市場相關調查分析,提供包含概要,各市場區隔預測,加上競爭情形,主要企業等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 抗體生產市場:變數·趨勢·範圍

  • 市場區隔·範圍
  • 推動市場要素分析
  • 阻礙市場要素分析
  • 主要的機會
  • SWOT分析
  • 波特的五力分析
  • 市場地位分析

第4章 抗體生產市場:各流程預測·趨勢分析

  • 各流程趨勢分析
  • 上游流程
  • 下游流程
  • 過濾

第5章 抗體生產市場:各類型預測·趨勢分析

  • 各類型趨勢分析
  • 多株抗體
  • 單株抗體

第6章 抗體生產市場:各最終用途預測·趨勢分析

  • 各最終用途趨勢分析
  • 醫藥品·生物科技企業
  • 研究機關
  • 其他

第7章 抗體生產市場:各地區的預測·趨勢分析

  • 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭情形

  • 企業簡介
    • GE Healthcare
    • Thermo Fisher Scientific, Inc.
    • Sartorius AG
    • Merck KGaA
    • Pall Corp.
    • Eppendorf AG
    • Cellab GmbH
    • INTEGRA Biosciences AG
目錄
Product Code: GVR-1-68038-698-1

The global antibody production market is expected to reach a value of USD 22.6 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives growth of the market during forecast period. Antibodies are the dominant biopharmaceuticals that specifically target the abnormal cells. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, rheumatic heart disease, and arthritis.

Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.

Further key findings from the study suggest:

  • Downstream processing was the largest revenue-grossing segment of the antibody production market in 2016. It is also expected to exhibit the highest CAGR during the forecast period, owing to large application of chromatography devices and resins in downstream processing
  • The monoclonal antibody segment was leading in 2016, due to its higher demand in treatment of chronic diseases including cancer, blood disorders, and growth hormone deficiency
  • The pharmaceutical and biotechnology companies segment dominated the overall market in terms of revenue in 2016, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development
  • North America was the largest revenue-generating region of the market in the year 2016. This region is expected to maintain its position during the forecast period because of the presence of several leading biopharmaceuticals and biotechnology companies in this region
  • Asia Pacific region is projected to be the fastest-growing segment over the study period, due to rapidly booming biotechnology industry and comparatively less stringent regulations for biologics development in APAC region
  • Some of the key players include GE Healthcare; Thermo Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf AG; Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.

Table of Contents

Chapter 1. Research Methodology

  • 1.1. Country Wise Market: Base Estimates
  • 1.2. Global Market: CAGR Calculation
  • 1.3. Region Based Segment Share Calculation
  • 1.4. Research Scope & Assumptions
  • 1.5. List of Data Sources
    • 1.5.1. Data for primary interviews, by sources
    • 1.5.2. Data for primary interviews, by region

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Antibody Production Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
  • 3.2. Market Driver Analysis
    • 3.2.1. Increased demand for therapeutic antibodies
    • 3.2.2. Increasing investment in R&D
    • 3.2.3. Rising adoption of targeted therapy
  • 3.3. Market Restraint Analysis
    • 3.3.1. Intense competition among vendors
    • 3.3.2. Stringent government regulations
  • 3.4. Key Opportunities Prioritized
    • 3.4.1. Key opportunities prioritized, by process
    • 3.4.2. Key opportunities prioritized, by type
    • 3.4.3. Key opportunities prioritized, by end-use
  • 3.5. Antibody Production-SWOT Analysis, by Factor(Political & Legal, Economic and Technological)
  • 3.6. Industry Analysis-Porter's
  • 3.7. Antibody Production Market: Market Position Analysis, 2016

Chapter 4. Antibody Production Market: Process Estimates & Trend Analysis

  • 4.1. Antibody Production Market: Process Movement Analysis
  • 4.2. Upstream processing
    • 4.2.1. Upstream processing market, 2014-2025(USD Million)
    • 4.2.2. Bioreactors
      • 4.2.2.1. Bioreactors market, 2014-2025(USD Million)
      • 4.2.2.2. Large-scale bioreactors
      • 4.2.2.2.1. Large-scale bioreactors market, 2014-2025(USD Million)
      • 4.2.2.3. Single-use bioreactors
      • 4.2.2.3.1. Single-use bioreactors market, 2014-2025(USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Consumables market, 2014-2025(USD Million)
      • 4.2.3.2. Media
      • 4.2.3.2.1. Media market, 2014-2025(USD Million)
      • 4.2.3.3. Buffers and reagents
      • 4.2.3.3.1. Buffers and reagents market, 2014-2025(USD Million)
  • 4.3. Downstream processing
    • 4.3.1. Downstream processing market, 2014-2025(USD Million)
    • 4.3.2. Chromatography systems
      • 4.3.2.1. Chromatography systems market, 2014-2025(USD Million)
    • 4.3.3. Chromatography resins
      • 4.3.3.1. Chromatography resins market, 2014-2025(USD Million)
  • 4.4. Filtration
    • 4.4.1. Filtration market, 2014-2025(USD Million)
    • 4.4.2. Filtration systems
      • 4.4.2.1. Filtration systems market, 2014-2025(USD Million)
    • 4.4.3. Filtration consumables and accessories
      • 4.4.3.1. Filtration consumables and accessories market, 2014-2025(USD Million)

Chapter 5. Antibody Production Market: Type Estimates & Trend Analysis

  • 5.1. Antibody Production Market: Type Movement Analysis
  • 5.2. Polyclonal antibody
    • 5.2.1. Polyclonal antibody market, 2014-2025(USD Million)
  • 5.3. Monoclonal antibody
    • 5.3.1. Monoclonal antibody market, 2014-2025(USD Million)
    • 5.3.2. Murine monoclonal antibody
      • 5.3.2.1. Murine monoclonal antibody market, 2014-2025(USD Million)
    • 5.3.3. Chimeric monoclonal antibody
      • 5.3.3.1. Chimeric monoclonal antibody market, 2014-2025(USD Million)
    • 5.3.4. Humanized monoclonal antibody
      • 5.3.4.1. Humanized monoclonal antibody market, 2014-2025(USD Million)

Chapter 6. Antibody Production Market: End-Use Estimates & Trend Analysis

  • 6.1. Antibody Production Market: End-Use Movement Analysis
  • 6.2. Pharmaceutical and biotechnology companies
    • 6.2.1. Pharmaceutical and biotechnology companies market, 2014-2025(USD Million)
  • 6.3. Research laboratories
    • 6.3.1. Research laboratories market, 2014-2025(USD Million)
  • 6.4. Others
    • 6.4.1. Pharmaceutical and biotechnology companies market, 2014-2025(USD Million)

Chapter 7. Antibody Production Market: Regional Estimates & Trend Analysis, by Process, Type, End-Use

  • 7.1. Antibody Production Market Share by Region, 2014 & 2025
  • 7.2. North America
    • 7.2.1. U.S.
      • 7.2.1.1. U.S. antibody production market, by process, 2014-2025(USD Million)
      • 7.2.1.2. U.S. antibody production market, by type, 2014-2025(USD Million)
      • 7.2.1.3. U.S. antibody production market, by end-use, 2014-2025(USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Canada antibody production market, by process, 2014-2025(USD Million)
      • 7.2.2.2. Canada antibody production market, by type, 2014-2025(USD Million)
      • 7.2.2.3. Canada antibody production market, by end-use, 2014-2025(USD Million)
  • 7.3. Europe
    • 7.3.1. Germany
      • 7.3.1.1. Germany antibody production market, by process, 2014-2025(USD Million)
      • 7.3.1.2. Germany antibody production market, by type, 2014-2025(USD Million)
      • 7.3.1.3. Germany antibody production market, by end-use, 2014-2025(USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK antibody production market, by process, 2014-2025(USD Million)
      • 7.3.2.2. UK antibody production market, by type, 2014-2025(USD Million)
      • 7.3.2.3. UK antibody production market, by end-use, 2014-2025(USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Japan
      • 7.4.1.1. Japan antibody production market, by process, 2014-2025(USD Million)
      • 7.4.1.2. Japan antibody production market, by type, 2014-2025(USD Million)
      • 7.4.1.3. Japan antibody production market, by end-use, 2014-2025(USD Million)
    • 7.4.2. China
      • 7.4.2.1. China antibody production market, by process, 2014-2025(USD Million)
      • 7.4.2.2. China antibody production market, by type, 2014-2025(USD Million)
      • 7.4.2.3. China antibody production market, by end-use, 2014-2025(USD Million)
    • 7.4.3. India
      • 7.4.3.1. India antibody production market, by process, 2014-2025(USD Million)
      • 7.4.3.2. India antibody production market, by type, 2014-2025(USD Million)
      • 7.4.3.3. India antibody production market, by end-use, 2014-2025(USD Million)
  • 7.5. Latin America
    • 7.5.1. Brazil
      • 7.5.1.1. Brazil antibody production market, by process, 2014-2025(USD Million)
      • 7.5.1.2. Brazil antibody production market, by type, 2014-2025(USD Million)
      • 7.5.1.3. Brazil antibody production market, by end-use, 2014-2025(USD Million)
    • 7.5.2. Mexico
      • 7.5.2.1. Mexico antibody production market, by process, 2014-2025(USD Million)
      • 7.5.2.2. Mexico antibody production market, by type, 2014-2025(USD Million)
      • 7.5.2.3. Mexico antibody production market, by end-use, 2014-2025(USD Million)
  • 7.6. MEA
    • 7.6.1. South Africa
      • 7.6.1.1. South Africa antibody production market, by process, 2014-2025(USD Million)
      • 7.6.1.2. South Africa antibody production market, by type, 2014-2025(USD Million)
      • 7.6.1.3. South Africa antibody production market, by end-use, 2014-2025(USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Profiles
    • 8.1.1. GE Healthcare
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial performance
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. Thermo Fisher Scientific, Inc.
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Sartorius AG
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Merck KGaA
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Pall Corp.
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Pall Corp.
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Eppendorf AG
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Cellab GmbH
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. INTEGRA Biosciences AG
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial performance
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. INTEGRA Biosciences AG
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial performance
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives

List of Tables

  • TABLE 1: Factors used in segment share estimation
  • TABLE 2: List of secondary data sources
  • TABLE 3: Primary interview details, by source
  • TABLE 4: Primary interview details, by region
  • TABLE 5: North America antibody production market, by country, 2014 - 2025 (USD Million)
  • TABLE 6: North America antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 7: North America antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 8: North America antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 9: U.S. antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 10: U.S. antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 11: U.S. antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 12: Canada antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 13: Canada antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 14: Canada antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 15: Europe antibody production market, by country, 2014 - 2025 (USD Million)
  • TABLE 16: Europe antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 17: Europe antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 18: Europe antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 19: Germany antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 20: Germany antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 21: Germany antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 22: UK antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 23: UK antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 24: UK antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 25: Asia Pacific antibody production market, by country, 2014 - 2025 (USD Million)
  • TABLE 26: Asia Pacific antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 27: Asia Pacific antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 28: Asia Pacific antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 29: Japan antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 30: Japan antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 31: Japan antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 32: China antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 33: China antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 34: China antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 35: India antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 36: India antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 37: India antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 38: Latin America antibody production market, by country, 2014 - 2025 (USD Million)
  • TABLE 39: Latin America antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 40: Latin America antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 41: Latin America antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 42: Brazil antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 43: Brazil antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 44: Brazil antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 45: Mexico antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 46: Mexico antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 47: Mexico antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 48: MEA antibody production market, by country, 2014 - 2025 (USD Million)
  • TABLE 49: MEA antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 50: MEA antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 51: MEA antibody production market, by end-use, 2014 - 2025 (USD Million)
  • TABLE 52: South Africa antibody production market, by process, 2014 - 2025 (USD Million)
  • TABLE 53: South Africa antibody production market, by type, 2014 - 2025 (USD Million)
  • TABLE 54: South Africa antibody production market, by end-use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1: Primary interviews, by sources
  • FIG. 2: Primary interviews, by region
  • FIG. 3: Market summary
  • FIG. 4: Market trends & outlook
  • FIG. 5: Market segmentation & scope
  • FIG. 6: Market driver relevance analysis (current & future impact)
  • FIG. 7: Key opportunities prioritized, by process
  • FIG. 8: Key opportunities prioritized, by type
  • FIG. 9: Key opportunities prioritized, by end-use
  • FIG. 10: SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 11: Porter's five forces analysis
  • FIG. 12: Antibody production market: Market position analysis, 2016
  • FIG. 13: Antibody production market process outlook: Key takeaways
  • FIG. 14: Antibody production market: Process movement analysis
  • FIG. 15: Upstream processing market, 2014 - 2025 (USD Million)
  • FIG. 16: Bioreactors market, 2014 - 2025 (USD Million)
  • FIG. 17: Large-scale bioreactors market, 2014 - 2025 (USD Million)
  • FIG. 18: Single-use bioreactors market, 2014 - 2025 (USD Million)
  • FIG. 19: Consumables market, 2014 - 2025 (USD Million)
  • FIG. 20: Media market, 2014 - 2025 (USD Million)
  • FIG. 21: Buffers and reagents market, 2014 - 2025 (USD Million)
  • FIG. 22: Downstream processing market, 2014 - 2025 (USD Million)
  • FIG. 23: Chromatography systems market, 2014 - 2025 (USD Million)
  • FIG. 24: Chromatography resins market, 2014 - 2025 (USD Million)
  • FIG. 25: Filtration market, 2014 - 2025 (USD Million)
  • FIG. 26: Filtration systems market, 2014 - 2025 (USD Million)
  • FIG. 27: Filtration consumables and accessories market, 2014 - 2025 (USD Million)
  • FIG. 28: Antibody production market type outlook: Key takeaways
  • FIG. 29: Antibody production market: Type movement analysis
  • FIG. 30: Polyclonal antibody market, 2014 - 2025 (USD Million)
  • FIG. 31: Monoclonal antibody market, 2014 - 2025 (USD Million)
  • FIG. 32: Murine monoclonal antibody market, 2014 - 2025 (USD Million)
  • FIG. 33: Chimeric monoclonal antibody market, 2014 - 2025 (USD Million)
  • FIG. 34: Humanized monoclonal antibody market, 2014 - 2025 (USD Million)
  • FIG. 35: Antibody production market end-use outlook: Key takeaways
  • FIG. 36: Antibody production market: End-use movement analysis
  • FIG. 37: Pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
  • FIG. 38: Research laboratories market, 2014 - 2025 (USD Million)
  • FIG. 39: Other end-use market, 2014 - 2025 (USD Million)
  • FIG. 40: Regional market place: Key takeaways
  • FIG. 41: Regional outlook, 2016 & 2025
Back to Top